Timothée Olivier, MD @Timothee_MD
Oncology (sarcoma, H&N, CUP). Research=EBM, Epi, Policy #metaresearch @HUG_ge (Geneva, CH), @vkprasadlab (UCSF). Geneva Ethics Committee. No COI. Views mine. timotheeolivier-research.com Genève, Suisse Joined December 2021-
Tweets2K
-
Followers1K
-
Following319
-
Likes2K
Check out our work led by @SruthiRanganat1 , with @VPrasadMDMPH 👇 Out today in @TheLancetOncol !
Check out our work led by @SruthiRanganat1 , with @VPrasadMDMPH 👇 Out today in @TheLancetOncol !
The fate of sotorasib: a @US_FDA regulatory failure potentially harming patients thelancet.com/journals/lanon… via @Timothee_MD et al
New in Perspectives: Quackery - The fate of #sotorasib: a regulatory failure potentially harming patients thelancet.com/journals/lanon…
I support science funding, obviously as someone who depends on it. But let's be honest: there's literally a 0.000% chance this funding was going to cure any cancer that is otherwise not going to be cured. Moonshot rhetoric is a misleading metaphor politico.com/news/2024/04/2…
Medicine by press release is so disappointing: - magnitude of PFS benefit is unknown - « clinically meaningful improvement in PFS » ⁉️ ➡️PFS is a time-to-event composite endpoint largely relying on CT scans arbitrary thresholds❗️ My take: looking forward to see the data!👇
Medicine by press release is so disappointing: - magnitude of PFS benefit is unknown - « clinically meaningful improvement in PFS » ⁉️ ➡️PFS is a time-to-event composite endpoint largely relying on CT scans arbitrary thresholds❗️ My take: looking forward to see the data!👇
To be honest, this is one of the best figure I have seen in the field ... so much informations, and so clear 💎! Well done Josh Elbaz, Alyson Haslam and Vinay Prasad ! @vkprasadlab 👇
To be honest, this is one of the best figure I have seen in the field ... so much informations, and so clear 💎! Well done Josh Elbaz, Alyson Haslam and Vinay Prasad ! @vkprasadlab 👇
Superb paper and thread 🧵providing an overview of the FDA regulatory pathway and highlighting the methods that Vinay has pioneered and developed in the field❗️ The alluvial diagram is so telling ! You should definitely bookmark it 👇
Superb paper and thread 🧵providing an overview of the FDA regulatory pathway and highlighting the methods that Vinay has pioneered and developed in the field❗️ The alluvial diagram is so telling ! You should definitely bookmark it 👇
Wow, I gave a talk to a small audience a few months ago on kaplan-meier plots. Now over 100,000 people have watched the video. Never would have guessed such a technical subject would capture the interest of so many.
Wow, I gave a talk to a small audience a few months ago on kaplan-meier plots. Now over 100,000 people have watched the video. Never would have guessed such a technical subject would capture the interest of so many.
@BrendonStilesMD @Alfdoc2 @JSabari @StephenVLiu @PatelOncology @NarjustFlorezMD @LealTiciana @IDEOlogyHealth @IASLC @Timothee_MD several issues-data is essentially uninterpretable. Discrepancies in reported deaths and higher censoring rates in TTFields group-raises issues w/data integrity and analysis. No molecular status data, reduced sample size raise concerns. Most important the limited treatment…
@BrendonStilesMD @JSabari @StephenVLiu @PatelOncology @NarjustFlorezMD @LealTiciana @IDEOlogyHealth @IASLC If it was a drug I would criticize it as much as now @Timothee_MD thelancet.com/journals/lanon…
re: MRD as an endpoint for accelerated approval. Vinay's voice seems strangely isolated in the Multiple Myeloma field. Vinay is bringing accurate questions❗️ Why is that? Could cultural, financial, or academic pressures be at play❓ @rajshekharucms @ManniMD1 @AaronGoodman33
re: MRD as an endpoint for accelerated approval. Vinay's voice seems strangely isolated in the Multiple Myeloma field. Vinay is bringing accurate questions❗️ Why is that? Could cultural, financial, or academic pressures be at play❓ @rajshekharucms @ManniMD1 @AaronGoodman33
Another way to look at it👇 (KEYNOTE 564 adj pembro renal) - 5.2% 4y absolute OS benefit - 8.8% of control pts receiving systemic therapy upon recurrence did NOT receive an anti-PD(L)1 (red bar) - 21.9% with recurrence (excl. deaths) did NOT receive an anti-PD(L)1 (green bar)
Another way to look at it👇 (KEYNOTE 564 adj pembro renal) - 5.2% 4y absolute OS benefit - 8.8% of control pts receiving systemic therapy upon recurrence did NOT receive an anti-PD(L)1 (red bar) - 21.9% with recurrence (excl. deaths) did NOT receive an anti-PD(L)1 (green bar) https://t.co/IOXqnkOJMy
The @NEJM just published the results of the KEYNOTE-564 trial by @Merck. Follow the ongoing KOL Discussions including physicians' praise of researchers @DrChoueiri @tompowles1 @TiansterZhang and criticism of the trial by @VPrasadMDMPH @Timothee_MD @drdgoldstein and others .…
@davidemccune @Timothee_MD We have been adding complexity (and cost) to clinical trials incessantly. Yet another obstacle for academic clinical trials.
@Timothee_MD I think we need a single, independent, oncology-specific scientific review committee for any pharma trial. Your typical IRB does not have the expertise to evaluate these issues. IRBs can handle the local implementation and human subjects protections.
Spending some time reading about QOL measures in oncology trials, & not feeling too reassured. Some issues I’ve seen: -Little consistency on what is considered clinically meaningful -Range of survey instruments used -Lots of drop off, particularly at later time points. If a…
Vinay Prasad MD MPH @VPrasadMDMPH
287K Followers 4K Following Prof @ucsf, Physician-Scientist, IG @vprasadmdmph @vkprasadlab @plenary_session, YouTube, #vpzd podcast & @Sensible__Med; Views mineAaron Goodman - “Pa.. @AaronGoodman33
135K Followers 428 Following Hematologist/Bone marrow transplanter at UCSD/educator - loves teaching all of Twitter medicine, husband+father/Guitar 🎸/Nirvana best band ever!/Loves tacosManni Mohyuddin @ManniMD1
12K Followers 491 Following Cancer doctor with interest in myeloma, supportive care, end of life, cost-effective/evidence-based care and med-ed. Views own.Bishal Gyawali @oncology_bg
15K Followers 803 Following Personal acc. Med Onc. A/Prof. @queensoncology @QueensuPHS. #cancerpolicy #cancergroundshot. Pubs: https://t.co/FTRPKNySfB Talks- https://t.co/anav3AJx9mAdam Cifu @adamcifu
25K Followers 812 Following Internist, professor, patient. Author: Ending Medical Reversal; Symptom to Diagnosis; Sensible Medicine. Podcasts: S2D & Clinical Excellence. Loves Baseball.John Mandrola, MD @drjohnm
66K Followers 2K Following Heart rhythm doc, writer for @Medscape, host of This Week in Cardiology podcast, cyclist, #MedicalConservative. The more you see, the harder medicine getsBijoy Telivala @BijoyTelivala
4K Followers 1K Following Partner physician at Cancer Specialists of North Florida , Jacksonville. All views are my own . Not medical advice Cricket/Pickleball/Bridge/Coffee /India/USAH. Jack West, MD @JackWestMD
22K Followers 3K Following VP of Clin Development, @summitplc; Founder,@CancerGRACE; fmr author/ed @UptoDate, fmr Web Ed @JAMAOnc & @MedscapeOnc columnist; Likes/RTs ≠ endorsementTracy Høeg, MD, PhD @TracyBethHoeg
80K Followers 1K Following PhD in epi & public health |Researcher @SyddanskUni & @ucsf |PM&R doc |🇩🇰🇺🇸 dual citizen |Run, bike swim; former team 🇺🇸 runner|6 languages |🏔️views mineJarushka Naidoo @DrJNaidoo
9K Followers 930 Following Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune toxicity | Adjunct faculty Johns Hopkins UniversityStephen V Liu, MD @StephenVLiu
24K Followers 3K Following Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Host @IASLC Podcast; Chair #DCLung24 #TexasLung24 #HereWeGoDr Amol Akhade @SuyogCancer
3K Followers 121 Following Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twistsAakash Desai, MD, MPH @ADesaiMD
5K Followers 1K Following Thoracic/Phase 1 Oncologist @ONealCancerUAB, Asst Prof @UABMedicine | Alum @MayoHemeOnc @UConnIM @MDAndersonNews| Co-Host @HemOncFellows @LungCancerRXAmar Kelkar, MD, MPH,.. @amarkelkar
4K Followers 5K Following BMT/Hematology👨🏾⚕️➡️@DanaFarber + @BrighamWomens + @harvardmed | #CareDelivery🔬| @HPJournalClub | @HarvardChanSPH MPH ‘23 | @Cornell ‘10 |❤️Heme & Policy🤓Raj Chakraborty @rajshekharucms
4K Followers 340 Following Hematologist/Oncologist/Clinical Researcher @ColumbiaCancer #Myeloma #Amyloidosis Asst. Prof @ColumbiaMed Host @BloodCancerTalk COI: https://t.co/du0rVMRFkCEddie Cliff @Eddie_Cliff
4K Followers 2K Following haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | host @BloodCancerTalkAndres Gomez @GomezDLeonMD
5K Followers 1K Following Associate Professor @UANL Monterrey, Mexico. Interested in HSCT, acute leukemia in LMIC. ASTCT. LABMT. ASH. AMEH. SMTT. #bmtsm #leusm #mmsm #lymsm #GlobalBMTPlenary Session Podca.. @Plenary_Session
11K Followers 39 Following Medicine, Oncology, Policy host @VPrasadMDMPH https://t.co/EhAIcGSW2Z @vkprasadlab https://t.co/7TCrcu2j7V Videos https://t.co/psQR3fM5V9…Alfredo Addeo MD @Alfdoc2
2K Followers 121 Following Medical Oncologist, department of oncology at the University hospital of Geneva (HUG). All opinions expressed here are my ownWolverHeme @WolverHeme
2K Followers 141 Following A hematology podcast by @berninini, @ajperissinotti, and friends! We nerd out and have a few drinks along the way! Disclaimer: views are our own!Anna Amela Valsecchi @AAValsecchi
74 Followers 97 Following Oncology Resident @unito 🌺 Ospedale Molinette, TorinoTrupti @Trupti2410
386 Followers 319 Following Associate Professor and Pathologist,TMH MUMBAI #lungcancer #MolecularPathology #breastcancer #dancer #fitnesslover ,T, RT personal opinions,not medical adviceRay Morikawa @808Raysan
1 Followers 19 FollowingWorld Journal of Onco.. @WJON_Journal
3K Followers 1K Following PubMed/PubMed Central/Scopus/EMbase/Web of Science (ESCI) indexed, JCR Impact Factor 2022: 5.2. Editor-in-Chief: Prof. Kazuaki Takabe, New York, USARadOnc @OncRad35517
15 Followers 52 FollowingRomain Brunel @DrRomainBrunel
31K Followers 1K Following Biólogo Molecular. Maestría Infectología, PhD Microbiología. Doctor pero no médico. Diagnóstico, antibióticos, infecciones. Opiniones personales. 🇫🇷➡️🇨🇴Rafik Nebbache @rafnbc
6 Followers 52 Following Interested in HN cancers, thoracic oncology and health publicManu Dhingra @manandhingra91
50 Followers 1K FollowingAmit Kulkarni @AmitKulkarniMD
1K Followers 2K Following Dad, Husband, Assistant Professor, Thoracic Oncologist, University of Minnesota | Masonic Cancer Centerblindoxygen @blindoxygen
8 Followers 17 FollowingEric Magliulo @ekmagliulo
88 Followers 343 FollowingOumaima Outani, MD @OOutani
2K Followers 5K Following 🇲🇦 MD | First Gen | Cat mom | Passionate about #Meded #narrativemedicine #Globalhealth | CPSolvers Academy member | IMF fellow Opinions my ownKeyan Aliaskari @keyanaliaskari
19 Followers 173 FollowingTim Richardson @Richematology
43 Followers 87 Following Hematologist and oncologist at the university of cologne in Germany. Myeloma management. Transplant treatmentTakuya Tomomatsu @TTomomat
3 Followers 43 FollowingShearwood McClelland .. @TheDrWood
790 Followers 386 Following Biblical Christian| Proverbs 3:5-6| #RadOnc & @NIH-funded Director of Spine Onc @RadoncUH @UHCLENeurosurg| @Harvard @ColumbiaPS 🇺🇸| PI @DrMcClellandLab| 💭=meM. El Mehdi م. ال�.. @melmehdi
1K Followers 2K Following Clinical Hematology Professor. Tweets about hematology, med education and music. Morocco. Blood: No Negative #bloodeducation #FreePalestine 🇵🇸Zivi @zhivile
111 Followers 205 FollowingShy fox @DrAksionav
12 Followers 6 FollowingSunilX @SunilXR
5 Followers 55 Following Physician at St. Olavs Hospital, Trondheim, Norway. Fan of Liverpool FC & cross country skiing.Visnja @visnja_markovic
56 Followers 482 FollowingApril Rose @DrDrAprilRose
726 Followers 928 Following Scientist, Medical Oncologist, Cancer Researcher, Mother of Dragons (she/her)Dr. Sabin Adhikari @DrSabinAC5908
152 Followers 1K Following Resident Doctor, Department of Clinical Oncology @ NAMS, Bir Hospital Breaking the stereotype Jaya Desh Nepal🇳🇵Darko Medin @MedinDarko
611 Followers 657 Following Senior Biostatistics Constultant. Data Scientist/Biology AI expert, Researcher. R and Python programmer. Contractor / Collaborating with CROs/AcademiaLeandro Piccoli @leandrogpiccoli
26 Followers 24 FollowingFeras Moria @MoriaFeras
125 Followers 812 Following Medical Oncology Fellow @mcgillu - Married to My Princess @raghad_hakim💍❤- AC Milan 🔴⚫ Al-Ahli FC 🐊 @kauweb 🇸🇦Dan Olson @DanielOlsonMD
485 Followers 644 Following Asst prof @UChicagoMed. Focus on melanoma and cancer immunotherapy // @rushumedcollege @NU_IntMed @UCHemOncFellows alum.Robert Souza @RobertS09515559
34 Followers 353 FollowingJennifer Williams @JenniferWi71087
1 Followers 6 FollowingAs @Azz12103
261 Followers 5K FollowingKathy Rose Esposito @K_Rose_E
908 Followers 3K Following Mom of 4, Guardian ad Litem, Boston born and raised. Love living in the South.Catherine Carly @tianluo81237865
36 Followers 210 Following Action is the fundamental key to all success. entrepreneur. philanthropist.Zoe Dikeman @ZDikema
49 Followers 5K FollowingJason @jasonwalker1490
20 Followers 45 FollowingAriadna Tibau Martore.. @ariadna_tibau
9 Followers 48 FollowingMatthew McInnes MD Ph.. @epi_rad
1K Followers 322 Following Professor of Radiology and Epidemiology, @uOttawaRad @uOttawa_SEPH @uOttawaMed Scientist OHRI Clinical Epidemiology Program @OttawaHospitalMartin Hong @mhong_88
62 Followers 76 Following Medical Oncology Trainee, nerd, getting in to the Twitter game. Opinions expressed are my owndranabalontoha @dranabalontoha
42 Followers 226 FollowingBitter @BitterBling
5 Followers 386 FollowingMahesh Kumar Kotha @MaheshK23576111
8 Followers 97 FollowingVinay Prasad MD MPH @VPrasadMDMPH
287K Followers 4K Following Prof @ucsf, Physician-Scientist, IG @vprasadmdmph @vkprasadlab @plenary_session, YouTube, #vpzd podcast & @Sensible__Med; Views mineAaron Goodman - “Pa.. @AaronGoodman33
135K Followers 428 Following Hematologist/Bone marrow transplanter at UCSD/educator - loves teaching all of Twitter medicine, husband+father/Guitar 🎸/Nirvana best band ever!/Loves tacosManni Mohyuddin @ManniMD1
12K Followers 491 Following Cancer doctor with interest in myeloma, supportive care, end of life, cost-effective/evidence-based care and med-ed. Views own.Bishal Gyawali @oncology_bg
15K Followers 803 Following Personal acc. Med Onc. A/Prof. @queensoncology @QueensuPHS. #cancerpolicy #cancergroundshot. Pubs: https://t.co/FTRPKNySfB Talks- https://t.co/anav3AJx9mJay Bhattacharya @DrJBhattacharya
502K Followers 6K Following Professor Stanford School of Medicine. MD, PhD. Health policy: infectious diseases, covid, health economics. Scientific freedom.Adam Cifu @adamcifu
25K Followers 812 Following Internist, professor, patient. Author: Ending Medical Reversal; Symptom to Diagnosis; Sensible Medicine. Podcasts: S2D & Clinical Excellence. Loves Baseball.Marty Makary MD, MPH @MartyMakary
240K Followers 1K Following @JohnsHopkins professor, @theNAMedicine member, @harvardchansph alum, author of 2 NYT bestselling books. Respect independent thinkers. Prefer data over dogmaJohn Mandrola, MD @drjohnm
66K Followers 2K Following Heart rhythm doc, writer for @Medscape, host of This Week in Cardiology podcast, cyclist, #MedicalConservative. The more you see, the harder medicine getschadi nabhan MD, MBA,.. @chadinabhan
19K Followers 782 Following Heme/Onc; NHL/HL/CLL. Adj Professor U of SC; Host: the #HealthcareUnfiltered & the #HemOnc Pulse podcasts. Author of "TOXIC EXPOSURE" & “THE CANCER JOURNEY.”Nico Gagelmann @NicoGagelmann
37K Followers 749 Following @TheEBMT_Trainee co-chair. Hematology. Medicine. Science. Train. Think. Implement an integral actuality.David Steensma, MD @DavidSteensma
25K Followers 463 Following Hematologist-oncologist. @AjaxThx CMO. Former Edward P. Evans Chair in MDS @DanaFarber, @HarvardMed & @MayoClinic faculty, @NovartisScience hematology head.Bijoy Telivala @BijoyTelivala
4K Followers 1K Following Partner physician at Cancer Specialists of North Florida , Jacksonville. All views are my own . Not medical advice Cricket/Pickleball/Bridge/Coffee /India/USAH. Jack West, MD @JackWestMD
22K Followers 3K Following VP of Clin Development, @summitplc; Founder,@CancerGRACE; fmr author/ed @UptoDate, fmr Web Ed @JAMAOnc & @MedscapeOnc columnist; Likes/RTs ≠ endorsementTracy Høeg, MD, PhD @TracyBethHoeg
80K Followers 1K Following PhD in epi & public health |Researcher @SyddanskUni & @ucsf |PM&R doc |🇩🇰🇺🇸 dual citizen |Run, bike swim; former team 🇺🇸 runner|6 languages |🏔️views mineJarushka Naidoo @DrJNaidoo
9K Followers 930 Following Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune toxicity | Adjunct faculty Johns Hopkins UniversitySamer Al Hadidi, MD,M.. @HadidiSamer
4K Followers 311 Following Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparitiesStephen V Liu, MD @StephenVLiu
24K Followers 3K Following Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Host @IASLC Podcast; Chair #DCLung24 #TexasLung24 #HereWeGoDr Amol Akhade @SuyogCancer
3K Followers 121 Following Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twistsDavid Russler-Germain.. @dgermain21
3K Followers 1K Following Oncology Instructor @SitemanCenter @WUSTLmed | lymphoma/leukemia researcher @LabFehniger | all views 100% my ownAmar Kelkar, MD, MPH,.. @amarkelkar
4K Followers 5K Following BMT/Hematology👨🏾⚕️➡️@DanaFarber + @BrighamWomens + @harvardmed | #CareDelivery🔬| @HPJournalClub | @HarvardChanSPH MPH ‘23 | @Cornell ‘10 |❤️Heme & Policy🤓Matthew Amusan @mkoamusan
340 Followers 227 Following Physician-Scientist. Loves Experimental & Translational Therapeutics. Local Man from Ibadan. A Learner.Vamsi Velcheti, MD MB.. @VamsiVelcheti
5K Followers 525 Following Professor of Medicine @ New York University, Director- Thoracic Oncology Program w/ focus on immunotherapy, epigenetics, phase 1 clinical trialsSanthosh Ambika @RenoHemonc
3K Followers 3K Following Oncologist/Hematologist- Doing my part to help onc patients. + fintwitMortality Watch @MortalityWatch
2K Followers 61 Following 📊 World's Largest Mortality Data Repository! 🗓️ Follow for automatic daily updates on new mortality data. 🗺️ Data Explorer: https://t.co/SuwwBe1cYWMassimo Di Maio @MassimoDiMaio75
3K Followers 3K Following Medical oncologist at Molinette Hospital, Turin. Professor of Medical Oncology at University of Turin. AIOM president elect #clinicaltrials #cancer #QoLUTSW Radiation Oncolo.. @UTSW_RadOnc
2K Followers 336 Following Welcome to the Department of Radiation Oncology at UT Southwestern, where state-of-the-art radiation technology meets human caring and compassion.Paul Windisch @windisch_paul
28 Followers 76 Following Physician Scientist with an interest for SoftwareKristoffer Magnusson @krstoffr
7K Followers 392 Following @[email protected] 🦣 Mostly stats, visualization, open science, and psychotherapy.Vanita Noronha, MBBS .. @VanitaNoronha
4K Followers 1K Following Med oncologist @TataMemorial. Ed-in-Chief @CRSTonline, https://t.co/Fr4aHwnOLX. Clinician, researcher, mother, reader. Tweets my own; RTs not endorsementsBen @USMortality
63K Followers 1K Following Software Engineer • COVID-19 Research, Bioinformatics & Statistics • Articles: https://t.co/NZl9auP70mSruthi Ranganathan @SruthiRanganat1
7 Followers 40 Following Medical Student, University of CambridgeJay Piccirillo, MD @PiccirilloJay
1K Followers 912 Following Professor, Vice Chair Research, and Director, Clinical Outcomes Research Office @wustl_ent; Program Director for TL1, R25 @wustlmed. Editor @jamaOTO.Corey Langer @CoreyLangerMD
1K Followers 297 Following Full time thoracic medical oncologist, husband, father and grandfather. Part time poet.Ticiana Batista (Leal.. @LealTiciana
2K Followers 558 Following Medical Thoracic Oncology, Clinical trials, lung cancerWaisse WAISSI, MD PhD @waissewaissi
183 Followers 229 Following Radiation oncologist 👨⚕️@clccleonberard, scientist 👨🔬 @Tirode_Lab , deciphering #sarcoma #cancerbiology to customize #RTdrugcomboAzra Raza @AzraRazaMD
3K Followers 359 Following Oncologist, Scientist, Author. Chan Soon-Shiong Professor of Medicine at @Columbia - Author of The First Cell @thefirstcell Get it here: https://t.co/RFbLEYHXnfKarine Tawagi MD @DrKarineTawagi
2K Followers 986 Following GU Oncologist | APD | 🇨🇦 GU & NOLA Heme/Onc Alumni | Interested in GU, Immuno Onc & Med Ed | @ASCO Featured Voice | @TwoOncDocs podcastMatthew Shun-Shin @mshunshin
858 Followers 437 Following Clinical Lecturer in Cardiology. Research interests: AI, Echocardiography, valvular heart disease, improving device therapies for heart failureRasha Al-Lamee @rallamee
6K Followers 541 Following Interventional Cardiology Consultant, Clinical Trialist, Imperial College London. Wife to a rugby obsessed husband and mum to a football obsessed sonMehrpouya Mobin @MehrpouyaMobin
715 Followers 814 Following Dedicated to science & management of cancer. Proud alumni of @RockefellerUniv & @ETH. Focus on Medical & #ThoracicOncology. Views = my own. RTs/Ls ≠ endorsementKaushal Parikh @kaushalpar
846 Followers 416 Following Thoracic oncologist @MayoCancerCare. Interest in phase 1 trials, immunotherapy, targeted therapies, thoracic malignancies. Views are my own. BOM➡️USATommy Etekal @t_etekal
106 Followers 241 Following Hematology fellow in probably the world's most northern BMT center.The Nobel Prize @NobelPrize
1.1M Followers 509 Following The official Twitter feed of the Nobel Prize @NobelPrize #NobelPrizeTwoOncDocs @TwoOncDocs
3K Followers 1K Following 🩸 a podcast about heme/onc for health care providers | ☕️ short high yield episodes to supplement your board review resources | @SamArmstrongMD @DrKarineTawagiCTOS @ctosociety
2K Followers 263 Following Medical professionals and scientists from around the world connect, collaborate, and share knowledge, experiences, and research for the treatment of sarcomas.Kim Lauper ☮️🕊.. @k_lauper
1K Followers 744 Following Consultant in the Division of Rheumatology @hug_ge, MD and Lecturer @UNIGEnews, @eular_org|@EMEUNET immediate past-chair, PhD in Epidemiology from @CfE_UoMWilliam A Hall, MD @whallradonc
2K Followers 397 Following Professor | Radiation Oncologist | Cancer Researcher | MR Guided RT | GI | GU | Tweets are my own opinion.Seth M Hardy, MD MBA @sethmhardy
2K Followers 357 Following Skeptic, Engineer, Pilot, Voxelpsychosocial Physician, Master in Organizational Sustainability, Phase II KM tick mark who is too honestEBHC Conference @ebhcconference
822 Followers 1K Following EBHC International Joint Conference - 25th-28th October 2023 #EBHC2023Reshma Jagsi @reshmajagsi
5K Followers 404 Following MD, DPhil | Oncologist, Equity Advocate, Bioethics Expert, Chair—Radiation Oncology @WinshipatEmory @emorymedicine | Views my ownTerry Friedlander @DrTFriedlander
184 Followers 63 Following Professor of Medicine at UCSF, Robert and Virginia O’Reilly Endowed Chair, and Chief, ZSFG Division of Hematology & OncologyKiu Tay-Teo @KiuTayTeo
56 Followers 56 FollowingLuca De Fiore @lucadf
3K Followers 1K Following Publisher @IlPensiero @RecentiProgMed | @forwardRPM | past president Italian Cochrane network | @EASEeditors Italian chapterAnushka Walia @anushka_walia4
74 Followers 73 Following medical student at UCSF | yale '21 | she/her i too morbidly long for the picturesque at all costsSAMO @SamoWorkshop
117 Followers 47 Following The Swiss Academy of Multidisciplinary Oncology provides continued education and exchange between various disciplines of cancer careJoseph Walker @joewalkerWSJ
5K Followers 1K Following Reporter at The Wall Street Journal @WSJ, covering pharma and biotech. Hello in there, hello.Marco Donia @DoniaMarco
577 Followers 219 Following Clinician-Scientist Oncologist @CCITdk, Assoc. Prof. @uni_copenhagen, #immunotherapy #melanoma #RWE #TIL #cancer. Web: https://t.co/WpfTMA5lg9BMC Series @BMC_series
22K Followers 3K Following A group of open access, peer reviewed journals spanning biological, physical, engineering and medical research. BMC series - Part of @BioMedCentralBrian Ramnaraign, MD .. @RamnaraignMD
361 Followers 233 Following Medical Oncologist at @UFHealthCancer and Assistant Professor of Medicine at @UFLi Haoran, MD, PhD @lihaoran
417 Followers 381 Following Medical oncologist @KUcancercenter. Previously @Huntsmancancer, @UofT & #SYSUCCKanekoaTheGreat @KanekoaTheGreat
761K Followers 2K Following Banned by Vijaya • Resurrected by Elon • Independent JournalistProf. Feynman @ProfFeynman
1.4M Followers 0 Following A universe of atoms, an atom in the universe. Tribute to the great explainer. Tweets about Science and Wisdom. Portrait by L.V Patten.Individual Daily Risk @medicalaxioms
70K Followers 5K Following I’m Mark Reid, MD. I made @MedicalAxioms. Now I’m writing a book called Individual Daily Risk that will change the way doctors & scientists interpret RCTs.Michael Shusterman, M.. @guildsman
682 Followers 203 Following GI Oncologist @Perlmutter_CC, Associate PD @nyulisom_HemOnc. Alum @StuyNY @TuftsUniversity @EinsteinMed @MontefioreNYC @WeillCornell. Tweets my own. #MededInterpolations @interpolated
2K Followers 1K Following Citizen-thinker. I’m like a cuttlefish. Call me Kevin. #science #COVID #openschools #philosophy #literature #photographyHôpital du Valais - .. @hopitalvs
1K Followers 104 Following Né en 2004 de la fusion de dix établissements, l’#hopitalduvalais affirme aujourd’hui sa présence sur l’ensemble du territoire cantonal valaisan.Niraj Shenoy, MD, PhD.. @NirajShenoy
163 Followers 96 Following Physician-Scientist. Cancer Biologist. GU Oncologist. Associate Professor @NUFeinbergMed @NorthwesternMed. PI, Shenoy Lab @LurieCancer. Dir, Kidney Cancer Res@Timothee_MD @SruthiRanganat1 @VPrasadMDMPH @TheLancetOncol Congratulations. Love having critical thinking minds next to me.. helps me to remain as much as possible down to earth
@Timothee_MD @TheLancetOncol @VPrasadMDMPH Lancet Oncology has a section called Quackery?
The fate of sotorasib: a @US_FDA regulatory failure potentially harming patients thelancet.com/journals/lanon… via @Timothee_MD et al
@Timothee_MD @VPrasadMDMPH @TheLancetOncol Huge congratulations @SruthiRanganat1. Outstanding work.
New in Perspectives: Quackery - The fate of #sotorasib: a regulatory failure potentially harming patients thelancet.com/journals/lanon…
I support science funding, obviously as someone who depends on it. But let's be honest: there's literally a 0.000% chance this funding was going to cure any cancer that is otherwise not going to be cured. Moonshot rhetoric is a misleading metaphor politico.com/news/2024/04/2…
Cette étude sur les mutations EGFR rares rencontrées dans les cancers du poumon à non petites cellules montre qu’il existe des solutions thérapeutiques: jto.org/article/S1556-… @Timothee_MD @Alfdoc2 @DOncologie @MDAndersonNews @portsmouthuni @MayoClinic #oncologie #recherche
... so you have to look at both regular and accelerated approvals based on surrogates. Here we follow out Cancer drugs spanning nearly 2 decades. This is what we find. This is the fate of all approvals. The green bar means the drug showed a survival benefit.
Thanks for this important and groundbreaking work. And continuing to try to improve evidence requirements for @fdacder approvals to protect patients.
#5. Thanks to @RFRedberg In 2015, she took a chance and published two papers from us Both used novel methods at the time 9 years later, several groups have a dozen papers using these methods for AA or non cancer drugs, and other coronary questions That's really validating!
Our latest paper led by med student Josh Elbaz👇 68% of cancer drug approvals don't have evidence they increase survival! Let me explain some key findings about the FDA #1. Both regular and accelerated approvals are based on surrogates... dx.doi.org/10.1002/cam4.7…
Wow, I gave a talk to a small audience a few months ago on kaplan-meier plots. Now over 100,000 people have watched the video. Never would have guessed such a technical subject would capture the interest of so many.
My primer on Kaplan Meier Plots How to read them, and some complexities Given to the UCSF IM Residency @UCSFIMChiefs Also available on Youtube at Vinay Prasad MD MPH channel
I never understood this take. So community oncologists who do the vast bulk of oncology care in the world and who have a good idea what their patients want have no say in randomized trials??? I guess leave it to the KOLs who travel weekly while others cover clinical care.
@ManniMD1 @JanakiramMurali @MyelomaAmateur I agree with @JanakiramMurali and @GKaurMD. There seems to be a deep chasm on this thread between physicians who recognize the complexity of randomized trials from having run them versus those who don’t, and I don’t foresee that changing anytime soon!
Fellows know that every time I am on service, I go down to Rads and look at images with Rads, and I learn so much that is not in the report. The only way to review images IMO. Plus their monitor set up is sick.
Thank a radiologist today for saving a life by writing in their report "please correlate clinically"
@BrendonStilesMD @Alfdoc2 @JSabari @StephenVLiu @PatelOncology @NarjustFlorezMD @LealTiciana @IDEOlogyHealth @IASLC @Timothee_MD several issues-data is essentially uninterpretable. Discrepancies in reported deaths and higher censoring rates in TTFields group-raises issues w/data integrity and analysis. No molecular status data, reduced sample size raise concerns. Most important the limited treatment…
@BrendonStilesMD @JSabari @StephenVLiu @PatelOncology @NarjustFlorezMD @LealTiciana @IDEOlogyHealth @IASLC If it was a drug I would criticize it as much as now @Timothee_MD thelancet.com/journals/lanon…
@Timothee_MD @rajshekharucms @AaronGoodman33 In my defense, I think the entire atmosphere/discussion was so polarizing. If you weren’t fully on board/pro MRD, you were perceived as being against your colleagues, against the benefit of patients, and thankless for all the hard work others have done. Was hard for me to offer…
Another way to look at it👇 (KEYNOTE 564 adj pembro renal) - 5.2% 4y absolute OS benefit - 8.8% of control pts receiving systemic therapy upon recurrence did NOT receive an anti-PD(L)1 (red bar) - 21.9% with recurrence (excl. deaths) did NOT receive an anti-PD(L)1 (green bar)
KEYNOTE-564 (adj pembro renal) show OS benefit BUT➡️Post-recurrence therapy is KEY in interpreting OS. Post-recurrence care in KEYNOTE-564 was clearly suboptimal. Would the benefit be seen with optimal post-recurrence care : that's the Q❗️ Visual here: timotheeolivier-research.com/postrecurrence
@PTsantoulis @Timothee_MD I don’t see it that way. A single review should be less work overall than the many independent reviews at new sites.
The @NEJM just published the results of the KEYNOTE-564 trial by @Merck. Follow the ongoing KOL Discussions including physicians' praise of researchers @DrChoueiri @tompowles1 @TiansterZhang and criticism of the trial by @VPrasadMDMPH @Timothee_MD @drdgoldstein and others .…
@davidemccune @Timothee_MD We have been adding complexity (and cost) to clinical trials incessantly. Yet another obstacle for academic clinical trials.